Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux

J Lipid Res. 2016 Mar;57(3):398-409. doi: 10.1194/jlr.M063842. Epub 2015 Dec 9.

Abstract

Studies in lipoprotein kinetics almost exclusively rely on steady-state approaches to modeling. Herein, we have used a non-steady-state experimental design to examine the role of cholesteryl ester transfer protein (CETP) in mediating HDL-TG flux in vivo in rhesus macaques, and therefore, we developed an alternative strategy to model the data. Two isotopomers ([(2)H11] and [(13)C18]) of oleic acid were administered (orally and intravenously, respectively) to serve as precursors for labeling TGs in apoB-containing lipoproteins. The flux of a specific TG (52:2) from these donor lipoproteins to HDL was used as the measure of CETP activity; calculations are also presented to estimate total HDL-TG flux. Based on our data, we estimate that the peak total postprandial TG flux to HDL via CETP is ∼ 13 mg · h(-1) · kg(-1) and show that this transfer was inhibited by 97% following anacetrapib treatment. Collectively, these data demonstrate that HDL TG flux can be used as a measure of CETP activity in vivo. The fact that the donor lipoproteins can be labeled in situ using well-established stable isotope tracer techniques suggests ways to measure this activity for native lipoproteins in free-living subjects under any physiological conditions.

Keywords: ProcessDB; cholesteryl ester transfer protein; high density lipoprotein; lipoproteins; non-steady-state dynamics; postprandial; rhesus macaques; triglyceride.

MeSH terms

  • Animals
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
  • Cholesterol Ester Transfer Proteins / metabolism*
  • Lipoproteins, HDL / blood
  • Lipoproteins, HDL / metabolism*
  • Macaca mulatta
  • Male
  • Models, Biological
  • Oxazolidinones / pharmacology*
  • Triglycerides / blood
  • Triglycerides / metabolism*

Substances

  • Cholesterol Ester Transfer Proteins
  • Lipoproteins, HDL
  • Oxazolidinones
  • Triglycerides
  • anacetrapib